Up Next
-
4m 19sPart 1 | Session 17 PAD in Germany 2009-2018 With Dr Rammos
-
3m 26sPart 1 | Session 18 LINC 22: IN.PACT Global Study 5-Y Diabetic & Gender Subgroup Outcomes
-
5m 20sPart 1 | Session 19 Patient Selection in NIVL and Preventing Migration in Venous Stenting
-
4m 28sPart 1 | Session 1 GPX Embolic Device In Peripheral Applications
-
5m 32sPart 1 | Session 2 B-CLEAR Registry: Timing of TEVAR in Type B Aortic Dissection
-
4m 16s
-
3m 58sPart 1 | Session 4 Cre8™ BTK Clinical Results in Complex BTK Patients
-
4m 25sPart 1 | Session 5 AVF Formation with Adjuvant Endovascular Maturation
-
6m 16sPart 1 | Session 6 Long-Term Results of Supera in AVF Junta-Anastomosis
-
6m 42sPart 1 | Session 7 SirPAD RCT: Sirolimus-Coated DCBs in Pts with PAD
-
2m 39sPart 1 | Session 8 PRELUDE-BTK With Dr Lichtenberg: Serranator® PTA in Pts With PAD
-
4m 46sPart 1 | Session 9 PRIZER Study: Renzan™ Stent in Pts With PAD
-
5m 16sPart 1 | Session 10 Auryon-SCE: Real-World Cohort Shows Promising Freedom from TLR at 6M
-
5m 32sPart 1 | Session 11 JET-RANGER: Jetstream Atherectomy & DCB In Pts With Complex Calcified Lesions
-
5m 43sPart 1 | Session 12 FLEX RCT: Micro-Incision prior to PTA in Pts With AVF
-
2m 46sPart 1 | Session 13 BioMimics 3D Stent: Safety and Efficacy in Real-World Patients
-
2m 44sPart 1 | Session 14 P-MAX Study with Dr Lichtenberg: ASPIREX®S Endovascular System
-
2m 15sPart 1 | Session 15 Cost-Effectiveness of Urea Excipient-Based DCBs for CLTI
Overview
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
Faculty Biographies
GA statistics 30d
133
GA statistics all time
1143